STEAP3 and metabolic dysfunction-associated steatotic liver disease: The absence of STEAP3 has been shown to impede the progression of non-alcoholic fatty liver disease (NAFLD), whereas its overexpression can lead to lipid accumulation within hepatic cells [17].